LEONARD JOHN M (President and CEO) received a stock award from INTELLIA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2025ACC: 0000950170-25-032248
DirectorOfficer· President and CEO
Since Mar 2026
+332K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
332K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+136K
Price / share
—
Trade value
—
% of position
14.5%
3/1/2025
941.12K→1.08M
Total
Net shares
+136K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | +136K | — | — | 14.5% | 941.12K | 1.08M |
| Total | +136K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
196K shares
Shares
+196K
Strike price
10.09
Held after
196K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock196K shares | 3/1/2025 | A · Award | +196K | 10.09 | — | 196K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned58.41K
Total
58.41K indirect58.41K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 58.41K | Indirect |
| Total | 58.41K | 58.41K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported